QUECTEL-WIRELESS
8.4.2024 10:01:34 CEST | Business Wire | Press release
Quectel Wireless Solutions, a global IoT solutions provider, is pleased to be showcasing some its industry leading IoT connectivity solutions and technologies, catering to various industries and applications at Embedded World 2024 in Nürnberg.
During the event, visitors can explore Quectel’s extensive portfolio of IoT modules and solutions designed to meet the diverse needs of the IoT ecosystem. From 5G and LTE-M/NB-IoT modules to GNSS positioning modules, Quectel offers a comprehensive range of products that empower businesses to build reliable, scalable, and future-proof IoT solutions.
In addition, Zeljko Maric, Product Development Manager at Quectel, will be participating in a panel session centered on IoT Modem Reference Design or IoT SoC Modules Modem for Embedded Designers. The session is scheduled to take place in the exhibitor forum, Hall 3, on Wednesday, April 10th, at 3:30 PM.
"We are excited to participate in Embedded World 2024 and showcase our latest innovations in IoT connectivity," said Norbert Muhrer, President and CSO, Quectel Wireless Solutions. "As a leading provider of IoT modules, Quectel is dedicated to empowering businesses worldwide with reliable, secure and innovative connectivity solutions. We look forward to engaging with industry peers, customers, and partners at the event."
Quectel is also highlighting some of its customers’ innovations during the show:
- Broadcast Sports International: 5G MT-UHD, an advanced 5G-enabled broadcasting tool that opens new horizons for live sports and events coverage.
- Consenz Head-up Display – equipped with the Quectel SC680A module, this cost-effective retrofit Head-Up Display (HUD) solution from Consenz enhances driving safety.
- Speed Tech Corporation /Luxshare-ict Precision 5G MiFi unit alongside their 5G Indoor CPE and 5G Outdoor CPE units.
- Microamp Solutions’ CellBox Air 5G mmWave Radio Unit is a system that connects to the Distributed Unit (DU) through the O-RAN 7.2x interface and features an integrated Massive MIMO antenna array.
- MikroTik’s Chateau 5G Router is a device that epitomizes the fusion of sophisticated design and powerful 5G connectivity, designed to cater to the growing demand for faster and more reliable home and office internet solutions.
- Monitair MonAir-CO2, a unique environmental sensor is equipped with the advanced Quectel EG915U LTE Cat1bis module and YC0002AA antenna, making it a one-of-a-kind 4G battery-operated device capable of meticulously tracking CO2, temperature, humidity, COV, NOX, and noise levels.
- Particle's M-SoM M404 M.2 system-on-module embeds multi-radio connectivity in IoT devices features LTE-M + 2G fallback + dual-band Wi-Fi and includes a high-end modern microcontroller with Arm TrustZone, secure boot, and capable of running Edge ML models, combined with a best-in-class Quectel connectivity module.
- PayEye eyePOS 3 - The world's only terminal to support iris and facial biometrics fusion and all types of cashless payments - card, contactless (NFC) and mobile, featuring the QUECTEL SC668S-EM.
- Sixfab will be showcasing a number of devices on the Quectel stand including the Jumpstart 5G, a fully certified, all-inclusive, ready-to-connect IoT computer for high-speed applications, a 4G/LTE Cellular Modem Kit for Raspberry Pi, a versatile 4G/LTE connectivity solution for Raspberry Pi and the Pico LTE, a comprehensive platform for global cellular connectivity & low-power IoT, pre-integrated with AWS IoT, Azure IoT & more.
- Ricon will be presenting the S9980DSL-LTEv2 High-Speed Fiber Optical xDSL Fixed/Wireless Router with Integrated 4.5G Cellular Interface and S9955OUT-5G Industrial Outdoor Router
- Roltek will be demonstrating their Edge Pro LTE8421 4G IOT Gateway, designed using the Quectel EG915 module to provide seamless and reliable connectivity even in challenging conditions
- ZCS Lawn Mower Robot: The ZCS autonomous lawn mower robot, powered by the Quectel LG69T Series module, an automotive grade dual-band multi-constellation GNSS module integrating DR/RTK, demonstrates the future of smart, connected landscaping.
As part of the Quectel stand, Ikotek, a leading IoT original design manufacturer (ODM), will be there to showcase its capabilities in IoT device design, manufacturing and certification delivering high quality products and services to reduce complexity, speed up time to market, eliminate risk and reduce costs.
Finally, Acceleronix, a global IoT solutions and services enablement provider primarily focused on serving OEMs and enterprises, will have a presence on the Quectel stand. Delivering edge-device management software, Connectivity-as-a-Service, specialized vertical software, and mobile applications, Acceleronix offers comprehensive solutions tailored to empower every facet of IoT product lifecycle, spanning from development to data management and visualization.
Attendees to Embedded World can find Quectel on stand 3-318.
About Quectel
Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of 5,900 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules as well as antennas and services.
With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.
For more information, please visit: www.quectel.com, LinkedIn, Facebook, and X.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240408354948/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom